On the Properties of Stochastic Multiple-Criteria Comparison Methods in Health Technology Assessment

• Autorzy: Bogumił Kamiński , Michał Jakubczyk
• Języki publikacji: EN

Abstrakty

EN

To ensure the optimal usage of scarce resources in the assessment of health technologies two criteria are used: costs and effectiveness of available options. For each treatment the evaluations of these criteria are obtained from clinical trials, cost and utility studies and therefore are given as random variables. In our research we compare the decision theoretic properties of expected net benefit, cost-effectiveness acceptability curve and expected value of perfect information methods of choosing the optimal treatment.(original abstract)

Słowa kluczowe

EN

Medical technology; Decision making under uncertainty; Cost-benefit analysis (CBA)

PL

Technologia medyczna; Podejmowanie decyzji w warunkach niepewności; Analiza kosztów i korzyści (AKK)

• Czasopismo: Multiple Criteria Decision Making / University of Economics in Katowice
• Rocznik: 2010
• Tom: 5
• Strony: 121--133

Twórcy

autor

Bogumił Kamiński

• Warsaw School of Economics, Poland

autor

Michał Jakubczyk

• Warsaw School of Economics, Poland

Bibliografia

• Bawa V.S.: Optimal Rules for Ordering Uncertain Prospects. "Journal of Financial Economics" 1975, 2, pp. 95-121.
• Blaker H., Spjotvoll E.: Paradoxes and Improvements in Interval Estimation. "The American Statistician" 2000, 54(4), pp. 242-247.
• Briggs A., Fenn PP.: Confidence Intervals or Surfaces? Uncertainty on the Cost-Effectiveness Plane. "Health Economics" 1998, 7, pp. 723-740.
• Briggs A.H., Sculpher M.J., Claxton K.: Decision Modeling for Health Economic Evaluation. Oxford University Press, New York 2006.
• Claxton K.: Bayesian Approaches to the Value of Information: Implications for the Regulation of New Pharmaceuticals. "Health Economics" 1999, 8, pp. 269-7.
• Drummond M.F.: Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press 1997.
• Fenwick E., Claxton K., Sculpher M.: Representing Uncertainty: the Role of Cost-Effectiveness Acceptability Curves. "Health Economics" 2001, 10, pp. 779-787.
• Garber A.M., Phelps C.E.: Economic Foundations of Cost-Effectiveness Analysis. "Journal of Health Economics" 1997, 16, pp. 1-31.
• Cost-Effectiveness in Health and Medicine. Eds. M.R. Gold, J.E. Siegel, L.B. Russel, M.C. Weinstein. Oxford University Press 1996.
• Hammond P.J.: Changing Tastes and Coherent Dynamic Choice. "Review of Economics Studies" 1976, 43(1), pp. 159-173.
• Hammond P.J.: Dynamic Restrictions on Metastatic Choice. "Economica" 1977, 44(176), pp. 337-350.
• Hodgson R.T.: The Problem of Being a Normal Deviate. "American Journal of Physics" 1979, 47(12), pp. 1092-1093.
• Hwang J.T.G.: Fieller's Problems and Resampling Techniques. "Statistica Sinica" 1995, 5, pp. 161-171.
• Jakubczyk M., Kamiński B.: Cost-Effectiveness Acceptability Curves - Caveats Quantified. Working paper, 2009.
• Laska E., Meisner M., Siegel C., Stinnett A.: Ratio-Based and net Benefit-Based Approaches to Health Care Resource Allocation: Proofs of Optimality and Equivalence. "Health Economics" 1999, 8, pp. 171-174.
• Löthgren M., Zethraeus N.: Definition, Interpretation and Calculation of Cost-Effectiveness Acceptability Curves. "Health Economics" 2000, 9, pp. 623-630.
• Sen A.: Internal Consistency of Choice. "Econometrica" 1993, 61, pp. 495-521.
• Stinnett A.A., Mullahy J.: Net Health Benefits: a New Framework for the Analysis of Uncertainty in Cost-Effectiveness Analysis. "Medical Decision Making" 1998, 18(2 Supp), pp. S65-S80.
• Tambour M., Zethraeus N., Johannesson M.: A Note on Confidence Intervals in Cost-Effectiveness Analysis. "International Journal of Technology Assessment in Health Care" 1998, 14, pp. 467-471.
• van Hout B.A., Al M.J., Gordon G.S., Rutten F.F.H.: Costs, Effects and C:E-ratios Alongside a Clinical Trial. "Health Economics" 1994, 3, pp. 309-319.